BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Soresi M, Giannitrapani L, D’Antona F, Florena AM, Spada EL, Terranova A, Cervello M, D’Alessandro N, Montalto G. Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol 2006; 12(16): 2563-2568 [PMID: 16688802 DOI: 10.3748/wjg.v12.i16.2563]
URL: https://www.wjgnet.com/1007-9327/full/v12/i16/2563.htm
Number Citing Articles
1
Jiangbo Zhang, Jin Cheng, Zhenzhen Zeng, Yongfeng Wang, Xiaojun Li, Qing Xie, Junqiao Jia, Ying Yan, Zhengyang Guo, Jian Gao, Mingjie Yao, Xiangmei Chen, Fengmin Lu. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinomaOncotarget 2015; 6(39): 42040 doi: 10.18632/oncotarget.5969
2
Chiara Braconi, Jon C. Henry, Takayuki Kogure, Thomas Schmittgen, Tushar Patel. The Role of MicroRNAs in Human Liver CancersSeminars in Oncology 2011; 38(6): 752 doi: 10.1053/j.seminoncol.2011.08.001
3
Timo Rath, Ulrike Billmeier, Maximilian J. Waldner, Raja Atreya, Markus F. Neurath. From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesisArchives of Toxicology 2015; 89(4): 541 doi: 10.1007/s00204-015-1461-5
4
Helene L. Kammoun, Tamara Louise Allen, Darren Colin Henstridge, Michael James Kraakman, Lone Peijs, Stefan Rose-John, Mark Anthony Febbraio, Matias A Avila. Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in micePLOS ONE 2017; 12(6): e0179099 doi: 10.1371/journal.pone.0179099
5
Lamiaa N. Hammad, Sahar M. Abdelraouf, Fetouh S. Hassanein, Walid A. Mohamed, Mona F. Schaalan. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: Potential biomarkers for a more favorable prognosis?Journal of Immunotoxicology 2013; 10(4): 380 doi: 10.3109/1547691X.2012.758198
6
Mohamed S. Othman, Ahmed M. Aref, Amal A. Mohamed, Wesam A. Ibrahim. Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian PatientsISRN Hepatology 2013; 2013: 1 doi: 10.1155/2013/412317
7
Masashi Narazaki, Tadamitsu Kishimoto. The Two-Faced Cytokine IL-6 in Host Defense and DiseasesInternational Journal of Molecular Sciences 2018; 19(11): 3528 doi: 10.3390/ijms19113528
8
Zeynep Firtina Karagonlar, Doğukan Koç, Eren Şahin, Sanem Tercan Avci, Mustafa Yilmaz, Neşe Atabey, Esra Erdal. Effect of adipocyte-secreted factors on EpCAM+/CD133+ hepatic stem cell populationBiochemical and Biophysical Research Communications 2016; 474(3): 482 doi: 10.1016/j.bbrc.2016.04.137
9
Wim Verlinden, Sven Francque, Luisa Vonghia. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 581 doi: 10.1007/978-94-007-7675-3_22
10
W. E. Naugler, T. Sakurai, S. Kim, S. Maeda, K. Kim, A. M. Elsharkawy, M. Karin. Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 ProductionScience 2007; 317(5834): 121 doi: 10.1126/science.1140485
11
Ken-ichi Yamada, Fumiya Mito, Yuta Matsuoka, Satsuki Ide, Kazushige Shikimachi, Ayano Fujiki, Daiki Kusakabe, Yuma Ishida, Masataka Enoki, Arisa Tada, Miyuki Ariyoshi, Toshihide Yamasaki, Mayumi Yamato. Fluorescence probes to detect lipid-derived radicalsNature Chemical Biology 2016; 12(8): 608 doi: 10.1038/nchembio.2105
12
Justin K. Messex, Crystal J. Byrd, Geou-Yarh Liou. Signaling of Macrophages that Contours the Tumor Microenvironment for Promoting Cancer DevelopmentCells 2020; 9(4): 919 doi: 10.3390/cells9040919
13
Shengli Tang, Zhisu Liu, Yongxi Zhang, Yueming He, Dingyu Pan, Yuanyuan Liu, Quanyan Liu, Zhonglin Zhang, Yufeng Yuan. Rather than Rs1800796 Polymorphism, Expression of Interleukin-6 Is Associated with Disease Progression of Chronic HBV Infection in a Chinese Han PopulationDisease Markers 2013; 35: 799 doi: 10.1155/2013/508023
14
Jeffrey K. Lee, Ricki Bettencourt, David Brenner, Thuy-Anh Le, Elizabeth Barrett-Connor, Rohit Loomba, Christian Herder. Association between Serum Interleukin-6 Concentrations and Mortality in Older Adults: The Rancho Bernardo StudyPLoS ONE 2012; 7(4): e34218 doi: 10.1371/journal.pone.0034218
15
Yaron Meirow, Julia Kanterman, Michal Baniyash. Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the FateFrontiers in Immunology 2015; 6 doi: 10.3389/fimmu.2015.00523
16
J Gong, J-P Zhang, B Li, C Zeng, K You, M-X Chen, Y Yuan, S-M Zhuang. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6ROncogene 2013; 32(25): 3071 doi: 10.1038/onc.2012.318
17
Dirk Schmidt-Arras, Stefan Rose-John. IL-6 pathway in the liver: From physiopathology to therapyJournal of Hepatology 2016; 64(6): 1403 doi: 10.1016/j.jhep.2016.02.004
18
Yong-Cang Wang, Ge-Liang Xu, Wei-Dong Jia, Sheng-Jin Han, Wei-Hua Ren, Wei Wang, Wen-Bin Liu, Chuan-Hai Zhang, Hao Chen. Estrogen Suppresses Metastasis in Rat Hepatocellular Carcinoma through Decreasing Interleukin-6 and Hepatocyte Growth Factor ExpressionInflammation 2012; 35(1): 143 doi: 10.1007/s10753-011-9299-3
19
Florence A. Servais, Mélanie Kirchmeyer, Matthias Hamdorf, Nadège W.E. Minoungou, Stefan Rose-John, Stephanie Kreis, Claude Haan, Iris Behrmann. Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp130, JAK1, and/or STAT3Molecular Therapy - Nucleic Acids 2019; 16: 419 doi: 10.1016/j.omtn.2019.03.007
20
Mao Zhang, Shun Zhang, Zhenjie Yang, Jie Hu, Weiyu Hu, Peng Sun, Liqun Wu, Bing Han. Association between the expression levels of IL‑6 and IL‑6R in the hepatocellular carcinoma microenvironment and postoperative recurrenceOncology Letters 2018;  doi: 10.3892/ol.2018.9557
21
Nathalie Théret, Fidaa Bouezzeddine, Fida Azar, Mona Diab-Assaf, Vincent Legagneux. ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma MicroenvironmentCancers 2021; 13(7): 1563 doi: 10.3390/cancers13071563
22
Paulina Kur, Agnieszka Kolasa-Wołosiuk, Kamila Misiakiewicz-Has, Barbara Wiszniewska. Sex Hormone-Dependent Physiology and Diseases of LiverInternational Journal of Environmental Research and Public Health 2020; 17(8): 2620 doi: 10.3390/ijerph17082620
23
Yan Deng, Meng Li, Jian Wang, Li Xie, Taijie Li, Yu He, Qinghua Lu, Ruolin Li, Aihua Tan, Xue Qin, Shan Li. Susceptibility to hepatocellular carcinoma in the Chinese population—associations with interleukin-6 receptor polymorphismTumor Biology 2014; 35(7): 6383 doi: 10.1007/s13277-014-1863-7
24
Mohamed Balaha, Samah Kandeel, Waleed Barakat. Carvedilol suppresses circulating and hepatic IL-6 responsible for hepatocarcinogenesis of chronically damaged liver in ratsToxicology and Applied Pharmacology 2016; 311: 1 doi: 10.1016/j.taap.2016.10.012
25
Jordi Ribera, Juan Rodríguez-Vita, Bernat Cordoba, Irene Portolés, Gregori Casals, Eudald Casals, Wladimiro Jiménez, Victor Puntes, Manuel Morales-Ruiz, Matias A. Avila. Functionalized cerium oxide nanoparticles mitigate the oxidative stress and pro-inflammatory activity associated to the portal vein endothelium of cirrhotic ratsPLOS ONE 2019; 14(6): e0218716 doi: 10.1371/journal.pone.0218716
26
Christa Buechler, Elisabeth Haberl, Lisa Rein-Fischboeck, Charalampos Aslanidis. Adipokines in Liver CirrhosisInternational Journal of Molecular Sciences 2017; 18(7): 1392 doi: 10.3390/ijms18071392
27
Willscott E. Naugler, Michael Karin. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancerTrends in Molecular Medicine 2008; 14(3): 109 doi: 10.1016/j.molmed.2007.12.007
28
Sylvia S. W. Ng, Hong Zhang, Lisa Wang, Deborah Citrin, Laura A. Dawson. Association of pro-inflammatory soluble cytokine receptors early during hepatocellular carcinoma stereotactic radiotherapy with liver toxicitynpj Precision Oncology 2020; 4(1) doi: 10.1038/s41698-020-0124-z
29
Lara Kern, Melanie Mittenbühler, Anna Vesting, Anna Ostermann, Claudia Wunderlich, F. Wunderlich. Obesity-Induced TNFα and IL-6 Signaling: The Missing Link between Obesity and Inflammation—Driven Liver and Colorectal CancersCancers 2018; 11(1): 24 doi: 10.3390/cancers11010024
30
Neele Schumacher, Stefan Rose-John, Dirk Schmidt-Arras. ADAM-Mediated Signalling Pathways in Gastrointestinal Cancer FormationInternational Journal of Molecular Sciences 2020; 21(14): 5133 doi: 10.3390/ijms21145133
31
Jeong Won Jang, Byong Sun Oh, Jung Hyun Kwon, Chan Ran You, Kyu Won Chung, Chul Seung Kay, Hyun Suk Jung. Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinomaCytokine 2012; 60(3): 686 doi: 10.1016/j.cyto.2012.07.017
32
Hayato Nakagawa, Shin Maeda, Haruhiko Yoshida, Ryosuke Tateishi, Ryota Masuzaki, Takamasa Ohki, Yoku Hayakawa, Hiroto Kinoshita, Minoru Yamakado, Naoya Kato, Shuichiro Shiina, Masao Omata. Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: An analysis based on gender differencesInternational Journal of Cancer 2009; 125(10): 2264 doi: 10.1002/ijc.24720
33
Juri Bergmann, Miryam Müller, Niklas Baumann, Manuel Reichert, Carola Heneweer, Julia Bolik, Karsten Lücke, Sabine Gruber, Antonella Carambia, Susanne Boretius, Ivo Leuschner, Thomas Becker, Björn Rabe, Johannes Herkel, F. Thomas Wunderlich, Hans‐Willi Mittrücker, Stefan Rose‐John, Dirk Schmidt‐Arras. IL‐6 trans‐signaling is essential for the development of hepatocellular carcinoma in miceHepatology 2017; 65(1): 89 doi: 10.1002/hep.28874
34
Lichao Yang, Chunmeng Wei, Yasi Li, Xiao He, Min He. miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkersBiomarkers in Medicine 2020; 14(15): 1485 doi: 10.2217/bmm-2020-0099
35
Reza Rahbari, Lisa Zhang, Electron Kebebew. Thyroid cancer gender disparityFuture Oncology 2010; 6(11): 1771 doi: 10.2217/fon.10.127
36
Melchiorre Cervello, James A. McCubrey, Antonella Cusimano, Nadia Lampiasi, Antonina Azzolina, Giuseppe Montalto. Targeted therapy for hepatocellular carcinoma: novel agents on the horizonOncotarget 2012; 3(3): 236 doi: 10.18632/oncotarget.466
37
Ssu-Chuan Lai, Yu-Ting Su, Ching-Chi Chi, Yung-Che Kuo, Kam-Fai Lee, Yu-Chih Wu, Pei-Chi Lan, Muh-Hwa Yang, Te-Sheng Chang, Yen-Hua Huang. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulationJournal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1442-2
38
Takao Nagashima, Akihito Maruyama, Yasuyuki Kamata, Seiji Minota. Unchanged serum viral load and liver function during tocilizumab treatment in a patient with rheumatoid arthritis and hepatitis C virus infectionRheumatology International 2012; 32(7): 2231 doi: 10.1007/s00296-011-2060-2
39
Antonia Mourtzikou, Maria Alepaki, Marilena Stamouli, Abraham Pouliakis, Anastasios Skliris, Petros Karakitsos. Evaluation of serum levels of IL-6, TNF-α, IL-10, IL-2 and IL-4 in patients with chronic hepatitisInmunología 2014; 33(2): 41 doi: 10.1016/j.inmuno.2014.01.001
40
Wim Verlinden, Sven Francque, Luisa Vonghia. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_22-1
41
Rashmi R. Shah, Robert L. Smith. Inflammation-Induced Phenoconversion of Polymorphic Drug Metabolizing Enzymes: Hypothesis with Implications for Personalized MedicineDrug Metabolism and Disposition 2015; 43(3): 400 doi: 10.1124/dmd.114.061093
42
K Yuan, Y Lei, H-N Chen, Y Chen, T Zhang, K Li, N Xie, K Wang, X Feng, Q Pu, W Yang, M Wu, R Xiang, E C Nice, Y Wei, C Huang. HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3Cell Death & Differentiation 2016; 23(4): 616 doi: 10.1038/cdd.2015.129
43
Yan Liu, Aiguo Liu, Huameng Li, Chenglong Li, Jiayuh Lin. Celecoxib Inhibits Interleukin-6/Interleukin-6 Receptor–Induced JAK2/STAT3 Phosphorylation in Human Hepatocellular Carcinoma CellsCancer Prevention Research 2011; 4(8): 1296 doi: 10.1158/1940-6207.CAPR-10-0317
44
Diego F. Calvisi, Valentina M. Factor, Snorri S. Thorgeirsson. Molecular Genetics of Liver Neoplasia2010; : 163 doi: 10.1007/978-1-4419-6082-5_9
45
Tomasz Mikuła, Mariusz Sapuła, Joanna Jabłońska, Joanna Kozłowska, Wojciech Stańczak, Dagny Krankowska, Alicja Wiercińska-Drapało. Significance of Heparin-Binding Protein and D-dimers in the Early Diagnosis of Spontaneous Bacterial PeritonitisMediators of Inflammation 2018; 2018: 1 doi: 10.1155/2018/1969108
46
YANG WANG, XUEQUN REN, CHAOYANG DENG, LU YANG, ERFU YAN, TAO GUO, YANMIN LI, MARVIN XUEJUN XU. Mechanism of the inhibition of the STAT3 signaling pathway by EGCGOncology Reports 2013; 30(6): 2691 doi: 10.3892/or.2013.2743
47
Bijun Qiu, Junqi Wang, Yingxue Yu, Chao Zhen, Jinyang Gu, Wenjun Liu, Yankai Wen, Lili Chen, Yueqiu Gao, Qiang Xia, Xiaoni Kong. DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cellsOncotarget 2017; 8(5): 8499 doi: 10.18632/oncotarget.14293
48
Marc Fiorucci, Steeve Boulant, Anne Fournillier, Jean Daniel Abraham, Jean Pierre Lavergne, Glaucia Paranhos-Baccala, Geneviève Inchauspé, Christine Bain. Expression of the alternative reading frame protein of Hepatitis C virus induces cytokines involved in hepatic injuries Journal of General Virology 2007; 88(4): 1149 doi: 10.1099/vir.0.82575-0
49
Guobin He, Debanjan Dhar, Hayato Nakagawa, Joan Font-Burgada, Hisanobu Ogata, Yuhong Jiang, Shabnam Shalapour, Ekihiro Seki, Shawn E. Yost, Kristen Jepsen, Kelly A. Frazer, Olivier Harismendy, Maria Hatziapostolou, Dimitrios Iliopoulos, Atsushi Suetsugu, Robert M. Hoffman, Ryosuke Tateishi, Kazuhiko Koike, Michael Karin. Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 SignalingCell 2013; 155(2): 384 doi: 10.1016/j.cell.2013.09.031
50
Denada Dibra, Lopa Mishra, Shulin Li. Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: An underappreciated symbiotic relationshipBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1846(1): 152 doi: 10.1016/j.bbcan.2014.05.001
51
Feng Liu, Wen Zhang, Fusheng Yang, Tingting Feng, Meng Zhou, Yuan Yu, Xiuping Yu, Weiming Zhao, Fan Yi, Wei Tang, Yi Lu. Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signalingScientific Reports 2016; 6(1) doi: 10.1038/srep21260
52
Aránzazu Sánchez, Isabel Fabregat. Genetically modified animal models recapitulating molecular events altered in human hepatocarcinogenesisClinical and Translational Oncology 2009; 11(4): 208 doi: 10.1007/s12094-009-0342-x
53
Etienne Malvoisin, Jean-Michel Livrozet, Djamila Makloufi, Nadine Vincent. Soluble chemokine receptor CXCR4 is present in human seraAnalytical Biochemistry 2011; 414(2): 202 doi: 10.1016/j.ab.2011.03.022
54
Abdel-Rahman N Zekri, Abeer A Bahnassy, Sabrin A Abdel-Wahab, Medhat M Khafagy, Samah A Loutfy, Hessam Radwan, Sabry M Shaarawy. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4Journal of Gastroenterology and Hepatology 2009; 24(3): 416 doi: 10.1111/j.1440-1746.2008.05699.x
55
Masaaki Miyakoshi, Masahiro Yamamoto, Hiroki Tanaka, Katsuhiro Ogawa. Serine 727 phosphorylation of STAT3: An early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamineMolecular Carcinogenesis 2014; 53(1): 67 doi: 10.1002/mc.21949
56
Koji Taniguchi, Michael Karin. IL-6 and related cytokines as the critical lynchpins between inflammation and cancerSeminars in Immunology 2014; 26(1): 54 doi: 10.1016/j.smim.2014.01.001
57
Vincent Wai-Sun Wong, Jun Yu, Alfred Sze-Lok Cheng, Grace Lai-Hung Wong, Hoi-Yun Chan, Eagle Siu-Hong Chu, Enders Kai-On Ng, Francis Ka-Leung Chan, Joseph Jao-Yao Sung, Henry Lik-Yuen Chan. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis BInternational Journal of Cancer 2009; 124(12): 2766 doi: 10.1002/ijc.24281
58
Ying Liu, Su-jun Gao, Bo-xiang Du, Jie-jun Wang. Association of IL-6 polymorphisms with hepatocellular carcinoma risk: evidences from a meta-analysisTumor Biology 2014; 35(4): 3551 doi: 10.1007/s13277-013-1469-5
59
Julia Kanterman, Moshe Sade-Feldman, Michal Baniyash. New insights into chronic inflammation-induced immunosuppressionSeminars in Cancer Biology 2012; 22(4): 307 doi: 10.1016/j.semcancer.2012.02.008
60
Sidrah Naseem, Tabinda Hussain, Sobia Manzoor. Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologiesCytokine & Growth Factor Reviews 2018; 39: 36 doi: 10.1016/j.cytogfr.2018.01.002
61
Sweeta R. Choudhari, Muhammad A. Khan, Genesis Harris, Donald Picker, Gary S. Jacob, Timothy Block, Kunwar Shailubhai. Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, AtiprimodMolecular Cancer Therapeutics 2007; 6(1): 112 doi: 10.1158/1535-7163.MCT-06-0561
62
Ulrike Maegdefrau, Stephanie Arndt, Georgi Kivorski, Claus Hellerbrand, Anja-Katrin Bosserhoff. Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinomaLaboratory Investigation 2011; 91(11): 1615 doi: 10.1038/labinvest.2011.123
63
Lydia Giannitrapani, Maurizio Soresi, Antonio Giacalone, Maria Elisa Campagna, Marta Marasà, Melchiorre Cervello, Salvatore Marasà, Giuseppe Montalto. IL-6 −174G/C Polymorphism and IL-6 Serum Levels in Patients with Liver Cirrhosis and Hepatocellular CarcinomaOMICS: A Journal of Integrative Biology 2011; 15(3): 183 doi: 10.1089/omi.2010.0093
64
Yan Liu, Aiguo Liu, Zhenghu Xu, Wenying Yu, Hong Wang, Chenglong Li, Jiayuh Lin. XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cellsApoptosis 2011; 16(5): 502 doi: 10.1007/s10495-011-0578-0